Unio Capital LLC Grows Stake in Intuitive Surgical, Inc. $ISRG

Unio Capital LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% during the second quarter, HoldingsChannel.com reports. The firm owned 67,943 shares of the medical equipment provider’s stock after buying an additional 1,705 shares during the period. Intuitive Surgical accounts for 5.1% of Unio Capital LLC’s portfolio, making the stock its 11th biggest position. Unio Capital LLC’s holdings in Intuitive Surgical were worth $27,019,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. Motiv8 Investments LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $34,000. Main Street Group LTD purchased a new stake in Intuitive Surgical in the first quarter valued at about $30,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the fourth quarter worth about $39,000. Vermillion Wealth Management Inc. grew its stake in shares of Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares during the last quarter. Finally, High Note Wealth LLC grew its stake in shares of Intuitive Surgical by 50.0% during the fourth quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 23 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the sale, the executive vice president directly owned 881 shares of the company’s stock, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president directly owned 5,320 shares in the company, valued at $2,016,280. This represents a 6.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 11,658 shares of company stock valued at $4,649,835. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ISRG. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. UBS Group initiated coverage on shares of Intuitive Surgical in a research report on Tuesday, July 28th. They set a “neutral” rating and a $500.00 target price on the stock. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Raymond James Financial reiterated an “outperform” rating and set a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Finally, Bank of America dropped their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $508.68.

Intuitive Surgical Trading Down 2.0%

ISRG opened at $369.25 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a 50 day moving average of $383.40 and a two-hundred day moving average of $430.61. The firm has a market capitalization of $130.45 billion, a PE ratio of 42.30, a P/E/G ratio of 2.72 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.81 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.